Kosan Biosciences Incorporated
Records under this name other than the patents Kosan Biosciences Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Kosan Biosciences Incorporated
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,446,196 | Leptomycin compounds Term ended Term ended Sep 23, 2026 · USPTO record | Term ended | Term ended Sep 23, 2026 | USPTO record |
| US 7,851,190 | Biosynthetic gene cluster for leptomycins Term ended Term ended Sep 13, 2026 · USPTO record | Term ended | Term ended Sep 13, 2026 | USPTO record |
| US 7,348,436 | Compounds useful for the synthesis of (+)-discodermolide and methods thereof Term ended Term ended May 31, 2026 · USPTO record | Term ended | Term ended May 31, 2026 | USPTO record |
| US 7,541,330 | Conjugates with reduced adverse systemic effects Term ended Term ended Apr 8, 2026 · USPTO record | Term ended | Term ended Apr 8, 2026 | USPTO record |
| US 7,238,816 | Preparation of Epothilone Derivatives Term ended Term ended Apr 7, 2026 · High confidence | Term ended | Term ended Apr 7, 2026 | High confidence |
| US 7,259,156 | Geldanamycin compounds and method of use Term ended Term ended Feb 11, 2026 · USPTO record | Term ended | Term ended Feb 11, 2026 | USPTO record |
| US 8,618,085 | Therapeutic formulations of desoxyepothilones Term ended Term ended Nov 30, 2025 · USPTO record | Term ended | Term ended Nov 30, 2025 | USPTO record |
| US 7,214,708 | Synthetic discodermolide analogs Term ended Term ended Oct 28, 2025 · USPTO record | Term ended | Term ended Oct 28, 2025 | USPTO record |
| US 8,063,021 | Ketolide anti-infective compounds Term ended Term ended Oct 28, 2025 · USPTO record | Term ended | Term ended Oct 28, 2025 | USPTO record |
| US 7,247,617 | Sixteen-member macrolide antiinfective agents Term ended Term ended Oct 7, 2025 · USPTO record | Term ended | Term ended Oct 7, 2025 | USPTO record |